Vericel Corp: Form 10-Q for the period ended Mar 31, 2018
Filed with the SEC on May 8, 2018 and accepted by EDGAR at May 8, 2018, 16:12 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-01-01 to 2018-03-31 | $18.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2018-01-01 to 2018-03-31 | $7.7m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2018-01-01 to 2018-03-31 | $10.4m | us-gaap:GrossProfit |
| Research and development | 3 months2018-01-01 to 2018-03-31 | $3.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2018-01-01 to 2018-03-31 | $11.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2018-01-01 to 2018-03-31 | −$4.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2018-01-01 to 2018-03-31 | $432.0k | us-gaap:InterestExpense |
| Net income | 3 months2018-01-01 to 2018-03-31 | −$7.7m | us-gaap:NetIncomeLoss |
| Operating cash flow | 3 months2018-01-01 to 2018-03-31 | $405.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2018-03-31 | $29.8m | us-gaap:Cash |
| Current assets | At period end2018-03-31 | $48.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-03-31 | $52.4m | us-gaap:Assets |
| Current liabilities | At period end2018-03-31 | $13.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-03-31 | $31.5m | us-gaap:Liabilities |
| Long-term debt | At period end2018-03-31 | $15.6m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2018-03-31 | $20.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-18-006239. Last ingested by Listed: Nov 14, 2026, 12:33 ET. Listed shows no prices and gives no investment advice.